Urinary urgency outcomes after propiverine treatment for an overactive bladder: the 'Propiverine study on overactive bladder including urgency data'

被引:31
|
作者
Lee, Kyu-Sung [12 ]
Lee, Hye Won [12 ]
Choo, Myung-Soo [11 ]
Paick, Jae-Seung [10 ]
Lee, Jeong Gu [9 ]
Seo, Ju Tae [8 ]
Lee, Jeong Zoo [2 ]
Lee, Young-Suk [12 ]
Yoon, Hana [7 ]
Park, Choal Hee [3 ]
Na, Yong-Gil [4 ]
Jeong, Young Beom [5 ]
Lee, Jong Bouk [1 ]
Park, Won Hee [6 ]
机构
[1] Natl Med Ctr, Seoul, South Korea
[2] Pusan Natl Univ, Coll Med, Pusan 609735, South Korea
[3] Keimyung Univ, Sch Med, Taegu, South Korea
[4] Chungnam Natl Univ, Coll Med, Taejon, South Korea
[5] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea
[6] Inha Univ, Coll Med, Inchon, South Korea
[7] Ewha Womans Univ, Sch Med, Seoul, South Korea
[8] Kwandong Univ, Coll Med, Seoul, South Korea
[9] Korea Univ, Coll Med, Seoul 136705, South Korea
[10] Seoul Natl Univ, Coll Med, Seoul, South Korea
[11] Univ Ulsan, Coll Med, Seoul, South Korea
[12] Sungkyunkwan Univ, Dept Urol, Samsung Med Ctr, Sch Med, Seoul, South Korea
关键词
overactive bladder; urinary urgency; propiverine hydrochloride; randomized trial; DOUBLE-BLIND; INCONTINENCE; SYMPTOMS; TOLERABILITY; TOLTERODINE; SOLIFENACIN; PERCEPTION; EFFICACY; TRIAL;
D O I
10.1111/j.1464-410X.2009.09050.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To investigate the effects of a daily regimen of propiverine 20 mg in patients with an overactive bladder (OAB), focused on improving urgency, as the clinical efficacy of treatment for OAB should be measured in terms of urgency, the cornerstone symptom of OAB. PATIENTS AND METHODS Eligible patients aged >= 18 years with symptoms of OAB were enrolled in this multicentre, prospective, parallel, double-blind, placebo-controlled trial. Of 264 patients (mean age 52.2 years), 221 who had efficacy data available from baseline and at least one on-treatment visit with > 75% compliance with medication were analysed (142 in the propiverine group and 79 in the placebo group). All patients were randomized to receive a placebo or 20 mg propiverine once daily in a 12-week study. They completed a 3-day voiding diary before visits during the study period, including the severity of urgency associated with every voiding, using the Indevus Urgency Severity Scale and the Urgency Perception Score. The patients' overall self-evaluation of treatment benefits at the end of the study, and safety data, were also collected. RESULTS The daily urgency episodes reduced significantly from baseline to 12 weeks on propiverine treatment, compared with placebo (-46.0% vs -31.3%, P = 0.005). Secondary endpoints, including sum of urgency severity per 24 h, urgency severity per void, and daytime voiding frequency, were also improved significantly in the propiverine group. Overall, of those patients treated with propiverine, 38.7% rated their treatment as providing 'much benefit', compared with 15.2% of the placebo group (P = 0.025). Adverse events reported by 32 (22.5%) and 10 (12.7%) patients in the propiverine and placebo group were all tolerable. However, this is a short-term study using only one fixed regimen. CONCLUSIONS Propiverine 20 mg once-daily could be an effective treatment for patients with OAB, by improving urgency.
引用
收藏
页码:1565 / 1570
页数:6
相关论文
共 50 条
  • [21] Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double-blind, placebo-controlled trial
    Gotoh, Momokazu
    Yokoyama, Osamu
    Nishizawa, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (05) : 365 - 373
  • [22] Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity
    Nitti, Victor W.
    Rovner, Eric S.
    Bavendam, Tamara
    BJU INTERNATIONAL, 2010, 105 (09) : 1268 - 1275
  • [23] Therapeutic effect of propiverine hydrochloride on mixed-type urinary incontinence in women: The Female Urgency and Stress Urinary Incontinence Study of Propiverine Hydrochloride trial
    Minagawa, Tomonori
    Gotoh, Momokazu
    Yokoyama, Osamu
    Sugaya, Kimio
    Yamanishi, Tomonori
    Kawahara, Kazuya
    Kaga, Kanya
    Kikuchi, Takashi
    Nishizawa, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 486 - 491
  • [24] The Role of Urgency, Frequency, and Nocturia in Defining Overactive Bladder Adaptive Behavior
    Minassian, Vatche
    Stewart, Walter
    Hirsch, Annemarie
    Kolodner, Ken
    Fitzgerald, Mary
    Burgio, Kathryn
    Cundiff, Geoffrey
    Blaivas, Jerry
    Newman, Diane
    Dilley, Anne
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (03) : 406 - 411
  • [25] Impact of daily number of urgency urinary incontinence episodes on overactive bladder patient reported outcomes
    Angulo, J. C.
    Brenes, F. J.
    Lizarraga, I.
    Rejas, J.
    Trillo, S.
    Ochayta, D.
    Arumi, D.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (03): : 173 - 182
  • [26] First North American experience of propiverine use in children with overactive bladder
    Lapointe, Elisabeth
    Singbo, Narcisse
    Naud, Elizabeth
    Bolduc, Stephane
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (10): : 358 - 363
  • [27] Considerations for the management of urgency symptoms in patients with overactive bladder syndrome
    Cardozo, Linda D.
    Van Kerrebroeck, Philip E. V. A.
    Staskin, David R.
    WORLD JOURNAL OF UROLOGY, 2009, 27 (06) : 755 - 763
  • [28] Korean Translation and Linguistic Validation of Urgency and Overactive Bladder Questionnaires
    Kim, Seung-Ee
    Lee, Hyo Serk
    Lee, Ha Na
    Lee, Seo Yeon
    Choo, Min Soo
    Park, Min Gu
    Chae, Ji Yun
    Oh, Seung-June
    Cho, Sung Yong
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2020, 24 (01) : 66 - 76
  • [29] Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladder
    Liao, Chun-Hou
    Kuo, Hann-Chorng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (03) : 700 - 706
  • [30] Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
    Lee, Raymond T.
    Bamberger, Mitchell
    Ellsworth, Pamela
    RESEARCH AND REPORTS IN UROLOGY, 2013, 5 : 147 - 157